Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy-Reference-Cited by-同舟云学术

Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy

Published:2020-04 Issue:2 Volume:11 Page:505-517
ISSN:2190-5991
Container-title:Journal of Cachexia, Sarcopenia and Muscle
language:en
Short-container-title:Journal of Cachexia, Sarcopenia and Muscle

Author:

Signorelli Mirko¹^ORCID,Ayoglu Burcu²^ORCID,Johansson Camilla³,Lochmüller Hanns⁴⁵⁶⁷^ORCID,Straub Volker⁸^ORCID,Muntoni Francesco⁹^ORCID,Niks Erik¹⁰^ORCID,Tsonaka Roula¹^ORCID,Persson Anja³,Aartsma‐Rus Annemieke⁶¹¹^ORCID,Nilsson Peter¹²^ORCID,Al‐Khalili Szigyarto Cristina²³^ORCID,Spitali Pietro¹¹^ORCID

Affiliation:

1. Department of Biomedical Data SciencesLeiden University Medical Center Leiden The Netherlands

2. Department of Protein Sciences, SciLifeLab, School of Engineering Sciences in Chemistry, Biotechnology and HealthKTH Royal Institute of Technology Stockholm Sweden

3. Department of Protein Science, School of Chemistry, Biotechnology and HealthKTH Royal Institute of Technology Stockholm Sweden

4. Department of Neuropediatrics and Muscle Disorders, Faculty of Medicine, Medical CenterUniversity of Freiburg Freiburg Germany

5. Centro Nacional de Análisis Genómico (CNAG‐CRG), Center for Genomic RegulationBarcelona Institute of Science and Technology (BIST) Barcelona Spain

6. Children's Hospital of Eastern Ontario Research InstituteUniversity of Ottawa Ottawa Canada

7. Division of Neurology, Department of MedicineThe Ottawa Hospital Ottawa Canada

8. MRC Centre for Neuromuscular Diseases, Institute of Genetic MedicineNewcastle University Newcastle upon Tyne UK

9. The Dubowitz Neuromuscular CentreUCL Institute of Child Health London UK

10. Department of NeurologyLeiden University Medical Center Leiden The Netherlands

11. Department of Human GeneticsLeiden University Medical Center Leiden The Netherlands

12. Division of Affinity Proteomics, SciLifeLab, Department of Protein ScienceKTH Royal Institute of Technology Stockholm Sweden

Funder

French Muscular Dystrophy Association

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcsm.12517

Reference66 articles.

1. Muscular dystrophies

2. Muscular dystrophy

3. Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database

4. The 6-Minute Walk Test and Person-Reported Outcomes in Boys with Duchenne Muscular Dystrophy and Typically Developing Controls: Longitudinal Comparisons and Clinically-Meaningful Changes Over One Year

5. Evaluation of the North Star Ambulatory Assessment scale and cardiac abnormalities in ambulant boys with Duchenne muscular dystrophy

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large scale serum proteomics identifies proteins associated with performance decline and clinical milestones in Duchenne muscular dystrophy;2024-08-07

2. Physiology of malate dehydrogenase and how dysregulation leads to disease;Essays in Biochemistry;2024-07-04

3. Sex and aging signatures of proteomics in human cerebrospinal fluid identify distinct clusters linked to neurodegeneration;2024-06-19

4. Draft Guidance for Industry Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, and Related Dystrophinopathies – Developing Potential Treatments for the Entire Spectrum of Disease;Journal of Neuromuscular Diseases;2024-03-05

5. N-terminal titin fragment: a non-invasive, pharmacodynamic biomarker for microdystrophin efficacy;Skeletal Muscle;2024-01-16